Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
CEBINA Bridge Capital is a venture capital firm founded in 2021, dedicated to investment and capital management in the biotechnology sector. The firm is headquartered in an undisclosed location and focuses on fostering pharmaceutical innovation through strategic collaborations. CEBINA Bridge Capital partners with CEBINA GmbH and Evotec International GmbH to identify and support drug discovery projects originating from universities and research institutions in Central and Eastern Europe.
Although specific details regarding the firm's team size, assets under management, or fund count are not available, its strategic partnerships position it as a key player in the biotechnology investment landscape. The firm aims to enhance access to emerging drug discovery projects, leveraging its connections within the region to advance the biotechnology sector.
CEBINA Bridge Capital invests primarily in the biotechnology sector, with a specific emphasis on drug discovery projects. The firm collaborates with CEBINA GmbH and Evotec International GmbH to identify promising opportunities from universities and research institutions in Central and Eastern Europe. This focus allows CEBINA Bridge Capital to tap into innovative research and development initiatives that have the potential to transform the pharmaceutical landscape.
While specific investment stages and check sizes are not detailed, the firm’s strategy revolves around fostering collaborations that can lead to successful drug development. CEBINA Bridge Capital seeks to partner with organizations that share its vision for advancing pharmaceutical innovation, making it an attractive option for startups in the biotech space.
What are CEBINA Bridge Capital's investment criteria?
CEBINA Bridge Capital focuses on drug discovery projects, particularly those emerging from universities and research institutions in Central and Eastern Europe. The firm looks for innovative ideas that have the potential to advance the biotechnology sector.
How can startups pitch to CEBINA Bridge Capital?
Currently, there is no specific pitch application process or contact information available for startups looking to engage with CEBINA Bridge Capital. Founders are encouraged to explore potential collaborations through their networks.
What makes CEBINA Bridge Capital different from other venture capital firms?
CEBINA Bridge Capital distinguishes itself through its strategic partnerships with CEBINA GmbH and Evotec International GmbH, which enhance its ability to identify and support innovative drug discovery projects in the biotechnology field.
What geographic areas does CEBINA Bridge Capital focus on?
The firm primarily targets projects in Central and Eastern Europe, leveraging its connections within this region to access emerging biotechnology innovations.
What is the firm's approach to post-investment involvement?
Details regarding CEBINA Bridge Capital's post-investment involvement are not publicly available. However, the firm's focus on strategic collaborations suggests an interest in actively supporting its portfolio companies.
What is the typical check size for investments made by CEBINA Bridge Capital?
Specific information regarding check sizes is not disclosed. The firm focuses on fostering partnerships that can lead to successful drug development, which may influence the size of its investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.